First decade anniversary of the United Kingdom National Alkaptonuria Centre

First decade anniversary of the United Kingdom National Alkaptonuria Centre

Bibliographic Details
Main Authors:	Milad Khedr, Nick Sireau, George Bou‐Gharios, Jim A. Gallagher, Lakshminarayan R. Ranganath
Format:	Article
Language:	English
Published:	Wiley 2023-03-01
Series:	JIMD Reports
Online Access:	https://doi.org/10.1002/jmd2.12340

Similar Items

Reversal of ochronotic pigmentation in alkaptonuria following nitisinone therapy: Analysis of data from the United Kingdom National Alkaptonuria Centre
by: Lakshminarayan R. Ranganath, et al.
Published: (2020-09-01)

Increased prevalence of Parkinson's disease in alkaptonuria
by: Lakshminarayan Ranganath, et al.
Published: (2023-07-01)

Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinone
by: R. Griffin, et al.
Published: (2018-10-01)

Evaluation of Homogentisic Acid, a Prospective Antibacterial Agent Highlighted by the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) Clinical Trial
by: Nicola Ooi, et al.
Published: (2023-06-01)

A patient survey on the impact of alkaptonuria symptoms as perceived by the patients and their experiences of receiving diagnosis and care
by: Mattias Rudebeck, et al.
Published: (2020-05-01)

Revisiting Quantification of Phenylalanine/Tyrosine Flux in the Ochronotic Pathway during Long-Term Nitisinone Treatment of Alkaptonuria
by: Lakshminarayan R. Ranganath, et al.
Published: (2022-09-01)

Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria—An approach using statistical modelling
by: Lakshminarayan R. Ranganath, et al.
Published: (2022-01-01)

Vitiligo, alkaptonuria, and nitisinone—A report of three families and review of the literature
by: Lakshminarayan Ranganath, et al.
Published: (2021-09-01)

Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment
by: Lakshminarayan R. Ranganath, et al.
Published: (2022-08-01)

Clinical development innovation in rare diseases: overcoming barriers to successful delivery of a randomised clinical trial in alkaptonuria—a mini-review
by: L. R. Ranganath, et al.
Published: (2023-01-01)

Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria
by: L. R. Ranganath, et al.
Published: (2022-09-01)

Analysis of the Phenotype Differences in Siblings with Alkaptonuria
by: Andrea Zatkova, et al.
Published: (2022-10-01)

Association of alkaptonuria and low dose nitisinone therapy with cataract formation in a large cohort of patients
by: Mohammad S. Z. Ahmad, et al.
Published: (2022-07-01)

Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC‐QTOF‐MS
by: Andrew S. Davison, et al.
Published: (2019-07-01)

Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolism
by: Brendan P. Norman, et al.
Published: (2022-07-01)

Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone
by: Lakshminarayan R Ranganath, et al.
Published: (2022-10-01)

Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria
by: L.R. Ranganath, et al.
Published: (2022-03-01)

Alkaptonuria: Current Perspectives
by: Zatkova A, et al.
Published: (2020-01-01)

Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
by: Andrew S. Davison, et al.
Published: (2022-05-01)

Comprehensive Biotransformation Analysis of Phenylalanine-Tyrosine Metabolism Reveals Alternative Routes of Metabolite Clearance in Nitisinone-Treated Alkaptonuria
by: Brendan P. Norman, et al.
Published: (2022-09-01)

Nutritional interventions for patients with alkaptonuria: A minireview
by: Imrich Richard, et al.
Published: (2023-01-01)

Treatment of osteoporotic fractures in alkaptonuria by teriparatide stimulates bone formation and decreases fracture rate – A report of two cases
by: L.R. Ranganath, et al.
Published: (2021-12-01)

Nitisinone Treatment Affects Biomarkers of Bone and Cartilage Remodelling in Alkaptonuria Patients
by: Federica Genovese, et al.
Published: (2023-07-01)

Improving the clinical accuracy and flexibility of the Alkaptonuria severity score index
by: Harriet E. O. Cant, et al.
Published: (2022-07-01)

The nutritional status of people with alkaptonuria: An exploratory analysis suggests a protein/energy dilemma
by: Shirley Judd, et al.
Published: (2020-05-01)

Alkaptonuria
by: G K Tharini, et al.
Published: (2011-01-01)

Long‐term low dose nitisinone therapy in adults with alkaptonuria shows no cognitive decline or increased severity of depression
by: Andrew S. Davison, et al.
Published: (2022-05-01)

Expression of tyrosine pathway enzymes in mice demonstrates that homogentisate 1,2‐dioxygenase deficiency in the liver is responsible for homogentisic acid‐derived ochronotic pigmentation
by: Peter J. M. Wilson, et al.
Published: (2021-03-01)

Ophthalmological Manifestations of Alkaptonuria
by: E. V. Denisova, et al.
Published: (2022-04-01)

Alkaptonuria: Case report
by: Swapna S Khatu, et al.
Published: (2015-01-01)

Alkaptonuria - Case report
by: Fernanda Helena Craide, et al.
Published: (2014-09-01)

A cost-of-illness analysis of the economic burden of obsessive-compulsive disorder in the United Kingdom
by: Naman Kochar, et al.
Published: (2023-11-01)

Effects of Nitisinone on Oxidative and Inflammatory Markers in Alkaptonuria: Results from SONIA1 and SONIA2 Studies
by: Daniela Braconi, et al.
Published: (2022-11-01)

Demographic, Phenotypic and Genotypic Features of Alkaptonuria Patients: A Single Centre Experience
by: Sebile Kılavuz, et al.
Published: (2018-03-01)

Fatal acute haemolysis and methaemoglobinaemia in a man with renal failure and Alkaptonuria – Is nitisinone the solution?
by: A.S. Davison, et al.
Published: (2020-06-01)

Quality of life of patients with alkaptonuria
by: A. V. Kuzin, et al.
Published: (2021-03-01)

Alkaptonuria - an atypical manifestation or management?
by: Maryam Musavi, et al.
Published: (2023-06-01)

First report of alkaptonuria in Peru
by: Daniel Guillén-Mendoza, et al.
Published: (2014-12-01)

Preventive use of nitisinone in alkaptonuria
by: Bruce H. R. Wolffenbuttel, et al.
Published: (2021-08-01)

Alcaptonúria (ocronose) Alkaptonuria (ochronosis)
by: Ricardo B. Cotias, et al.
Published: (2006-12-01)